Citius Pharmaceuticals, Inc. Equity Issued in Business Combination, Fair Value Disclosure
Citius Pharmaceuticals, Inc. (CTXR) had Equity Issued in Business Combination, Fair Value Disclosure of $67.50 million as of 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:EquityIssuedInBusinessCombinationFairValueDisclosure · last filed 2024-08-12
- 2024-06-30: Equity Issued in Business Combination, Fair Value Disclosure $67.50M.
| Period end | Equity Issued in Business Combination, Fair Value Disclosure |
|---|---|
| 2024-06-30 | $67.50M 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |